Hailey Huerter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hailey Huerter has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Bumsuk Hahm
Departments of Surgery & Molecular Microbiology and Immunology, University of Missouri, Columbia, MO 65212, USA
2 shared publications - Dong Xu
Department of Electrical Engineering and Computer Science, and Christopher S. Bond Life Sciences Center, University of Missouri, Columbia, MO, USA
2 shared publications Lei Jiang
Department of Electrical Engineering and Computer Science, University of Missouri , Columbia, MO
2 shared publicationsYing He
Department of Surgery, University of Missouri , Columbia, MO
2 shared publicationsCaleb J Studstill
Department of Surgery, University of Missouri , Columbia, MO
1 shared publicationJulie D. Saba
Department of Pediatrics, University of California San Francisco, CA, USA
1 shared publication
Latest Publications
- 10 July 2026
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (7)
CD22 is upregulated and displays suppressive properties on CD4+ T cells upon a persistent virus infection
Chronic viral infections evade or suppress host immunity, posing risks to global human health. However, the underlying mechanisms of viral immune suppression are incompletely defined. Previously, we have demonstrated that sphingosine kinase 2 (SphK2) represses CD4+ T-cell immunity during lymphocytic choriomeningitis virus (LCMV) Clone 13 (Cl 13) infection. Here, our study indicates that CD22 is significantly upregulated on virus-specific T cells, which is largely dependent on SphK2, upon LCMV infection. The upregulation of CD22 on virus-specific T cells is sustained during persistent LCMV Cl 13 infection. While transient depletion of CD22 modestly enhances LCMV-specific T-cell responses, complete deletion of CD22 does not significantly affect T-cell immunity, suggesting the presence of a compensatory mechanism. Adoptively transferred CD22-deficient T-cell receptor transgenic LCMV-specific CD4+ T cells expand more effectively and exhibit improved functionality compared to CD22-sufficient T-cell counterparts. The results indicate that CD22 has a CD4+ T cell–intrinsic suppressive function during infection. Analysis of gene signature profiling further supports the regulatory role of CD22 in LCMV-specific CD4+ T cells. Collectively, the SphK2-CD22 axis during CD4+ T-cell immunity to infection could advance our understanding of virus-instigated immune suppression and viral persistence.
- 10 July 2026
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 215 (7)
CD22 is upregulated and displays suppressive properties on CD4+ T cells upon a persistent virus infection
Chronic viral infections evade or suppress host immunity, posing risks to global human health. However, the underlying mechanisms of viral immune suppression are incompletely defined. Previously, we have demonstrated that sphingosine kinase 2 (SphK2) represses CD4+ T-cell immunity during lymphocytic choriomeningitis virus (LCMV) Clone 13 (Cl 13) infection. Here, our study indicates that CD22 is significantly upregulated on virus-specific T cells, which is largely dependent on SphK2, upon LCMV infection. The upregulation of CD22 on virus-specific T cells is sustained during persistent LCMV Cl 13 infection. While transient depletion of CD22 modestly enhances LCMV-specific T-cell responses, complete deletion of CD22 does not significantly affect T-cell immunity, suggesting the presence of a compensatory mechanism. Adoptively transferred CD22-deficient T-cell receptor transgenic LCMV-specific CD4+ T cells expand more effectively and exhibit improved functionality compared to CD22-sufficient T-cell counterparts. The results indicate that CD22 has a CD4+ T cell–intrinsic suppressive function during infection. Analysis of gene signature profiling further supports the regulatory role of CD22 in LCMV-specific CD4+ T cells. Collectively, the SphK2-CD22 axis during CD4+ T-cell immunity to infection could advance our understanding of virus-instigated immune suppression and viral persistence.
- Open Access
Sphingosine 1-phosphate lyase expressed in pulmonary epithelial cells potentiates host innate defenses and alleviates influenza pathogenicity in mice
Influenza viruses circulate in humans, causing a substantial burden on global health. Investigation of influenza-host interactions could identify host factors that regulate influenza pathogenicity. Sphingosine 1-phosphate (S1P) is a bioactive lipid mediator and regulates crucial cellular processes. S1P lyase (SPL), an enzyme that mediates S1P degradation, was shown to display anti-influenza activity in a cell culture system. Here, we constructed a mouse model to demonstrate the antiviral function of SPL in respiratory epithelial cells during influenza in vivo. Deletion of SPL from lung epithelial cells exacerbated influenza-induced weight loss and mortality. Influenza virus began to propagate more effectively in the absence of SPL at the innate immune stage. Increased virus titers were sustained during influenza and associated with enhanced accumulation of multiple immune cell types in the lungs. Single-cell RNA sequencing was conducted to further define the function of SPL in lung epithelial cells. SPL deletion increased the proportion of alveolar type 1 (AT1) cells compared to alveolar type 2 (AT2) cells with alteration of the related signaling pathways, suggesting a role of SPL in AT1/AT2 programming. Importantly, host innate defense pathways were changed in SPL-deficient lung epithelial cells upon infection, which corroborates the antiviral function of SPL. This study elucidates the host protective function of SPL in lung epithelial cells during influenza and provides gene signature profiles critical for SPL-mediated alleviation of influenza pathogenicity. The findings may contribute to development of host-directed therapeutics to better control influenza.
Open AccessSphingosine 1-phosphate lyase expressed in pulmonary epithelial cells potentiates host innate defenses and alleviates influenza pathogenicity in mice
Influenza viruses circulate in humans, causing a substantial burden on global health. Investigation of influenza-host interactions could identify host factors that regulate influenza pathogenicity. Sphingosine 1-phosphate (S1P) is a bioactive lipid mediator and regulates crucial cellular processes. S1P lyase (SPL), an enzyme that mediates S1P degradation, was shown to display anti-influenza activity in a cell culture system. Here, we constructed a mouse model to demonstrate the antiviral function of SPL in respiratory epithelial cells during influenza in vivo. Deletion of SPL from lung epithelial cells exacerbated influenza-induced weight loss and mortality. Influenza virus began to propagate more effectively in the absence of SPL at the innate immune stage. Increased virus titers were sustained during influenza and associated with enhanced accumulation of multiple immune cell types in the lungs. Single-cell RNA sequencing was conducted to further define the function of SPL in lung epithelial cells. SPL deletion increased the proportion of alveolar type 1 (AT1) cells compared to alveolar type 2 (AT2) cells with alteration of the related signaling pathways, suggesting a role of SPL in AT1/AT2 programming. Importantly, host innate defense pathways were changed in SPL-deficient lung epithelial cells upon infection, which corroborates the antiviral function of SPL. This study elucidates the host protective function of SPL in lung epithelial cells during influenza and provides gene signature profiles critical for SPL-mediated alleviation of influenza pathogenicity. The findings may contribute to development of host-directed therapeutics to better control influenza.